BACKGROUND: Infants <6 months old with influenza are at risk for adverse outcomes. Our objective was to compare influenza outcomes in infants <6 months old born to women who did and did not report influenza vaccine during pregnancy. METHODS: The study included all women who delivered from 12/2005 to 3/2014 at Intermountain facilities and their infants. Influenza outcomes included infant influenza-like illness (ILI), laboratory-confirmed influenza, and influenza hospitalizations. RESULTS: The cohort included 245 386 women and 249 387 infants. Overall, 23 383 (10%) pregnant women reported influenza immunization. This number increased from 2.2% before the H1N1 pandemic to 21% postpandemic (P < .001). A total of 866 infants <6 months old had ≥1 ILI encounter: 32 (1.34/1000) infants born to women reporting immunization and 834 (3.70/1000) born to women who did not report immunization (relative risk [RR] 0.36; 95% confidence interval [CI], 0.26-0.52; P < .001). A total of 658 infants had laboratory-confirmed influenza: 20 (0.84/1000) born to women reporting immunization and 638 (2.83/1000) born to unimmunized women (RR 0.30; 95% CI, 0.19-0.46; P < .001). A total of 151 infants with laboratory-confirmed influenza were hospitalized: 3 (0.13/1000) born to women reporting immunization and 148 (0.66/1000) born to unimmunized women (RR 0.19; 95% CI, 0.06-0.60; P = .005). CONCLUSIONS: Self-reported influenza immunization during pregnancy was low but increased after the H1N1 pandemic. Infants born to women reporting influenza immunization during pregnancy had risk reductions of 64% for ILI, 70% for laboratory-confirmed influenza, and 81% for influenza hospitalizations in their first 6 months. Maternal influenza immunization during pregnancy is a public health priority.
BACKGROUND:Infants <6 months old with influenza are at risk for adverse outcomes. Our objective was to compare influenza outcomes in infants <6 months old born to women who did and did not report influenza vaccine during pregnancy. METHODS: The study included all women who delivered from 12/2005 to 3/2014 at Intermountain facilities and their infants. Influenza outcomes included infant influenza-like illness (ILI), laboratory-confirmed influenza, and influenza hospitalizations. RESULTS: The cohort included 245 386 women and 249 387 infants. Overall, 23 383 (10%) pregnant women reported influenza immunization. This number increased from 2.2% before the H1N1 pandemic to 21% postpandemic (P < .001). A total of 866 infants <6 months old had ≥1 ILI encounter: 32 (1.34/1000) infants born to women reporting immunization and 834 (3.70/1000) born to women who did not report immunization (relative risk [RR] 0.36; 95% confidence interval [CI], 0.26-0.52; P < .001). A total of 658 infants had laboratory-confirmed influenza: 20 (0.84/1000) born to women reporting immunization and 638 (2.83/1000) born to unimmunized women (RR 0.30; 95% CI, 0.19-0.46; P < .001). A total of 151 infants with laboratory-confirmed influenza were hospitalized: 3 (0.13/1000) born to women reporting immunization and 148 (0.66/1000) born to unimmunized women (RR 0.19; 95% CI, 0.06-0.60; P = .005). CONCLUSIONS: Self-reported influenza immunization during pregnancy was low but increased after the H1N1 pandemic. Infants born to women reporting influenza immunization during pregnancy had risk reductions of 64% for ILI, 70% for laboratory-confirmed influenza, and 81% for influenza hospitalizations in their first 6 months. Maternal influenza immunization during pregnancy is a public health priority.
Authors: Eric K France; Renae Smith-Ray; David McClure; Simon Hambidge; Stanley Xu; Kristi Yamasaki; David Shay; Eric Weintraub; Alicia M Fry; Steve B Black; Henry R Shinefield; John P Mullooly; Lisa A Jackson Journal: Arch Pediatr Adolesc Med Date: 2006-12
Authors: Shabir A Madhi; Clare L Cutland; Locadiah Kuwanda; Adriana Weinberg; Andrea Hugo; Stephanie Jones; Peter V Adrian; Nadia van Niekerk; Florette Treurnicht; Justin R Ortiz; Marietjie Venter; Avy Violari; Kathleen M Neuzil; Eric A F Simões; Keith P Klugman; Marta C Nunes Journal: N Engl J Med Date: 2014-09-04 Impact factor: 91.245
Authors: Katherine A Poehling; Kathryn M Edwards; Marie R Griffin; Peter G Szilagyi; Mary A Staat; Marika K Iwane; Beverly M Snively; Cynthia K Suerken; Caroline B Hall; Geoffrey A Weinberg; Sandra S Chaves; Yuwei Zhu; Monica M McNeal; Carolyn B Bridges Journal: Pediatrics Date: 2013-01-06 Impact factor: 7.124
Authors: Steven B Black; Henry R Shinefield; Eric K France; Bruce H Fireman; Sharon T Platt; David Shay Journal: Am J Perinatol Date: 2004-08 Impact factor: 1.862
Authors: K Zaman; Eliza Roy; Shams E Arifeen; Mahbubur Rahman; Rubhana Raqib; Emily Wilson; Saad B Omer; Nigar S Shahid; Robert F Breiman; Robert E Breiman; Mark C Steinhoff Journal: N Engl J Med Date: 2008-09-17 Impact factor: 91.245
Authors: Nicholas T Conway; Zoe V Wake; Peter C Richmond; David W Smith; Anthony D Keil; Simon Williams; Heath Kelly; Dale Carcione; Paul V Effler; Christopher C Blyth Journal: J Pediatric Infect Dis Soc Date: 2012-09-03 Impact factor: 3.164
Authors: Ousseny Zerbo; G Thomas Ray; Lea Zhang; Kristin Goddard; Bruce Fireman; Alyce Adams; Saad Omer; Martin Kulldorff; Nicola P Klein Journal: Am J Epidemiol Date: 2020-11-02 Impact factor: 4.897
Authors: Benjamin J S Al-Haddad; Elizabeth Oler; Blair Armistead; Nada A Elsayed; Daniel R Weinberger; Raphael Bernier; Irina Burd; Raj Kapur; Bo Jacobsson; Caihong Wang; Indira Mysorekar; Lakshmi Rajagopal; Kristina M Adams Waldorf Journal: Am J Obstet Gynecol Date: 2019-06-15 Impact factor: 8.661
Authors: Jannat Saini; Mallory K Ellingson; Richard H Beigi; Noni E MacDonald; Karina A Top; Sarah Carroll; Saad B Omer Journal: Hum Vaccin Immunother Date: 2021-07-08 Impact factor: 4.526
Authors: Deshayne B Fell; Kumanan Wilson; Robin Ducharme; Steven Hawken; Ann E Sprague; Jeffrey C Kwong; Graeme Smith; Shi Wu Wen; Mark C Walker Journal: PLoS One Date: 2016-08-03 Impact factor: 3.240